Related Experiment Video
Updated: Jan 3, 2026

06:06
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
Published on: December 20, 2024
1.1K
Bacteriotherapy in Breast Cancer
Atieh Yaghoubi1,2, Majid Khazaei3, Seyed Mahdi Hasanian4
1Antimicrobial Resistance Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad 91387-35499, Iran.
International Journal of Molecular Sciences
|November 28, 2019
Summary
Exploring novel breast cancer treatments, this review highlights bacteria
Area of Science:
- Oncology
- Microbiology
- Biotechnology
Background:
- Breast cancer remains a leading cause of mortality in women globally.
- Conventional treatments like chemotherapy face challenges in efficacy.
- Emerging research suggests bacteria may offer novel therapeutic avenues for breast cancer.
Purpose of the Study:
- To review the potential of bacteria and their products in treating breast cancer.
- To explore the therapeutic applications of bacterial peptides, bacteriocins, and toxins.
- To discuss the role of genetically modified bacteria in cancer therapy.
Main Methods:
- Literature review of studies on bacterial therapy for breast cancer.
- Analysis of research on bacterial products (peptides, bacteriocins, toxins).
- Examination of genetically engineered bacteria for targeted cancer treatment.
Main Results:
- Some bacteria exhibit selective toxicity towards cancer cells with low impact on normal cells.
- Live, attenuated, or genetically modified bacteria can colonize tumors and inhibit growth.
- Bacterial products show promise as anti-cancer agents.
Conclusions:
- Bacteria and their derivatives represent a promising area for developing new breast cancer treatments.
- Genetic engineering can enhance bacterial therapy efficacy and safety.
- Further research into bacterial-based strategies is warranted for improved patient outcomes.
Related Concept Videos
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Microorganisms in Medicine and Therapeutics
886
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
886
Lytic Cycle of Bacteriophages
77.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.2K
Bacterial Signaling
39.9K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
39.9K

